PD ISO/TS 20399-3:2018 Biotechnology. Ancillary materials present during the production of cellular therapeutic products. Best practice guidance for ancillary material users

Find Similar Items

This product falls into the following categories.

You may find similar items within these categories by selecting from the choices below:

PD ISO/TS 20399-3:2018

Biotechnology. Ancillary materials present during the production of cellular therapeutic products. Best practice guidance for ancillary material users

Status : Current   Published : December 2018

Format
PDF

Format
HARDCOPY



What is this standard about?

This document provides guidance for ancillary material (AM) users. It is applicable to cellular therapeutic products, including those gene therapy products whereby cells form part of the final product. It does not apply to products without cells.

This document focuses primarily on ancillary materials (AMs) of biological (human and animal) origin and their potential impurities and contaminants.

NOTE 1 The decision chart in Figure 1 illustrates the rationale underlying the scope of this document.

However, diverse biological sources, including plants, insects and marine organisms, can also be used in the development of a cellular therapeutic product. Therefore the fundamental principles of risk management also apply for these sources of AMs.

This document does not cover the selection, assessment or control of starting materials and excipients. However, it is anticipated that these are still covered by general risk management procedures.

This document is applicable for users at all stages of clinical development and supply; however maximum benefits can be gained by the implementation of the recommendations in the early stages of development.

NOTE 2 International, regional or national regulations or requirements can also apply to specific topics covered in this document.




Standard NumberPD ISO/TS 20399-3:2018
TitleBiotechnology. Ancillary materials present during the production of cellular therapeutic products. Best practice guidance for ancillary material users
StatusCurrent
Publication Date07 December 2018
Cross ReferencesISO/TS 20399-1, ISO 13485, ISO 9001
International RelationshipsISO/TS 20399-3:2018
DescriptorsProducts, Cells (biology), Ancillary, Production, Biotechnology
ICS07.080
Title in FrenchBiotechnologie. Matériaux auxiliaires présents lors de la production de produits thérapeutiques cellulaires Lignes directrices de bonne pratique pour les utilisateurs de matériaux auxiliaires
CommitteeBTI/1
ISBN978 0 580 94263 1
PublisherBSI
FormatA4
DeliveryYes
Pages20
File Size510 KB
Price£126.00


 Your basket
Your basket is empty

Take the smart route to manage medical device compliance


BSOL

The faster, easier way to work with standards


Worldwide Standards
We can source any standard from anywhere in the world


Collaborate, Innovate, Accelerate.